US court invalidates Velcade patent after Sandoz challenge


Sandoz, Allergan and Accord Healthcare have demonstrated “clear and convincing” evidence that a patent owned by Millennium Pharmaceuticals and used in its Velcade (bortezomib) cancer treatment drug is invalid, according to a US court ruling.

Sandoz; Actavis; Accord Healthcare; Takeda; Millennium; Velcade; patent; US District Court for the District of Delaware